Details of Disease

General Information of Disease (ID: DISRGC2W)

Disease Name Encephalopathy
Disease Class 8E47: Encephalopathy
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISRGC2W: Encephalopathy
ICD Code
ICD-11
ICD-11: 8E47
ICD-10
ICD-10: G93.4
Expand ICD-11
'8E47; '8E4A.0; '8E63
Expand ICD-10
'G93.4
Disease Identifiers
MONDO ID
MONDO_0006741
MESH ID
D004678
UMLS CUI
C0014068
MedGen ID
4936
HPO ID
HP:0040197
SNOMED CT ID
58762006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Fosdenopterin DMR0TYK Approved Small molecular drug [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
BQ788 DM6KRLW Phase 3 Small molecular drug [2]
SA-237 DM7F2VG Phase 3 NA [3]
MEDI-551 DMBTVFE Phase 2 Antibody [3]
PU-AD DMKSU35 Phase 1 NA [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 ClinicalTrials.gov (NCT02047461) Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)